Shares of Eli Lilly and Company (NYSE:LLY – Get Free Report) shot up 1.5% during mid-day trading on Friday . The stock traded as high as $800.17 and last traded at $799.89. 814,889 shares were ...

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50 ...

Pending the FDA’s decision, compounding pharmacies will remain free to make and market versions of the blockbuster weight-loss therapy. Eli Lilly’s weight-loss therapy tirzepatide remains in limbo as ...

Chinese biotech Laekna Therapeutics on Wednesday announced a clinical collaboration with Eli Lilly (NYSE:LLY) to develop an obesity therapy that can avoid loss of muscle mass, a problem often ...

Arguably, no big pharma stocks have dominated the industry more over the last few years than Eli Lilly (NYSE: LLY) and Pfizer (NYSE: PFE). When the COVID-19 pandemic began in 2020, Pfizer quickly ...

Lilly and Pfizer stocks have sold off sharply in recent weeks. Both drugmakers have had some bad news that caused their stock declines. However, there's more to the story for both Lilly and Pfizer ...

Nov 20 (Reuters) - Eli Lilly (LLY.N), opens new tab and Hong Kong-listed Laekna (2105.HK), opens new tab will collaborate to develop an experimental obesity drug that aims to help patients lose ...

Eli Lilly shares tumble 12.5% in November, on track for their worst monthly performance since February 2009’s 20.2% drop. Past sell-offs signal resilience: LLY averaged double-digit rebounds one ...

Lilly estimates that about 20% of people in the U.S., or 63 million individuals, deal with high levels of Lp(a), which can greatly increase the risk of heart attack and lead to other ...

Analyst David Risinger of Leerink Partners reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), retaining the price target of $970.00. Don't Miss our Black Friday Offers ...